Consistently, DDX39B deficiency not only inhibited tumor growth in subcutaneous tumor models in nude mice (51), but also suppressed spleen metastases in an orthotopic transplantation model of CRC and lung metastasis in a CRC model via tail-vein injection (50, 51). This evidence concerns the gene DDX39B and colorectal carcinoma.